Connection

Abdullah Assiri to Cyclopropanes

This is a "connection" page, showing publications Abdullah Assiri has written about Cyclopropanes.
Connection Strength

0.037
  1. High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1-infected patients with severe chronic kidney disease. Liver Int. 2018 08; 38(8):1395-1401.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.